Table 2 and Figure 1 and Figure 2 present levels of systemic inflammation (expressed as CRP) and DNA/RNA damage in the groups of patients and controls, depending on the presence (or absence) of MetS. This evidence concerns the gene CRP and metabolic syndrome.